Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Justin B. Klee Insider Profile
4 Followers
Justin B. Klee, Co- CEO, Director at Amylyx Pharmaceuticals Inc, holds 3.14M shares in Amylyx Pharmaceuticals Inc (Ticker: AMLX).
Justin B. Klee Amylyx Pharmaceuticals Inc (AMLX)Co- CEO, Director
Amylyx Pharmaceuticals Inc (AMLX)
Co- CEO, Director
Ranked #5,389 out of 98,743 Corporate Insiders
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+152.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
Co- CEO, Director
Roles that Justin B. Klee holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 06, 2022 - May 06, 2023
Return:+279.60%
The most profitable trade made by Justin B. Klee
Justin B. Klee's Trading History
List of latest transactions for each holding click on a transaction to see Justin B. Klee's performance on stock
You May Also Like
Justin B. Klee insider profile FAQ
What is the percentage of profitable transactions made by Justin B. Klee?
The percentage of profitable transactions made by Justin B. Klee is 100%.
What is the average return per transaction made by Justin B. Klee?
The average return per transaction made by Justin B. Klee is 152.00%.
What stocks does Justin B. Klee hold?
Justin B. Klee holds: AMLX stocks.
What was Justin B. Klee’s latest transaction?
Justin B. Klee latest transaction was an Uninformative Buy of ―.
What was Justin B. Klee's most profitable transaction?
Justin B. Klee’s most profitable transaction was an Informative Buy of AMLX stock on May 6, 2022. The return on the trade was 279.60%.
What is Justin B. Klee's role in Amylyx Pharmaceuticals Inc?
Justin B. Klee's role in Amylyx Pharmaceuticals Inc is Co- CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.